AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
6min chapter
#400 Antiplatelets, Anticoagulation for Coronary Artery Disease and Afib
The Curbsiders Internal Medicine Podcast
The Future of P2Y12 Inhibitors
There are five trials now looking at stopping the aspirin instead of the P2Y12. That's mostly not in patients with AFib. But some of that we do see in patients withAFib as well. E2Y12s, again, give us benefit over aspirin in terms of reducing ischemic events. And in general, they're better than aspirin interms of bleeding as well. So win-win.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode